Faculty Information |
|
Article types | Original article |
Language | English |
Refereed paper | Not refereed |
Title | Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial. |
Journal | Formal name:The Lancet. Haematology Abbreviation:Lancet Haematol ISSN code:2352302623523026 |
Volume, Number, Page | 2(12),pp.e528-35 |
Papers・Author | Imagawa Jun, Tanaka Hideo, Okada Masaya, Nakamae Hirohisa, Hino Masayuki, Murai Kazunori, Ishida Yoji, Kumagai Takashi, Sato Seiichi, Ohashi Kazuteru, Sakamaki Hisashi, Wakita Hisashi, Uoshima Nobuhiko, Nakagawa Yasunori, Minami Yosuke, Ogasawara Masahiro, Takeoka Tomoharu, Akasaka Hiroshi, Utsumi Takahiko, Uike Naokuni, Sato Tsutomu, Ando Sachiko, Usuki Kensuke, Morita Satoshi, Sakamoto Junichi, Kimura Shinya, |
Publication date | 2015/12 |
DOI | 10.1016/S2352-3026(15)00196-9 |
PMID | 26686407 |